13 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

  • Tonix Pharmaceuticals, Inc. TNXP stock moved upwards by 40.2% to $1.36 during Thursday's pre-market session. The market value of their outstanding shares is at $4.6 million.
  • Amneal Pharmaceuticals, Inc. AMRX shares surged 20.3% to $4.20. The market cap seems to be at $959.2 million. According to the most recent rating by JP Morgan, on November 12, the current rating is at Underweight.
  • Veru, Inc. VERU stock surged 4.5% to $2.56. The market cap seems to be at $127.4 million.
  • Forty Seven, Inc. FTSV stock increased by 4.5% to $37.56. The market cap stands at $292.0 million. The most recent rating by Guggenheim, on December 11, is at Buy, with a price target of $48.00.
  • Genfit, Inc. GNFT shares increased by 3.6% to $16.21. The market cap stands at $552.9 million.
  • Canopy Growth, Inc. CGC shares increased by 2.2% to $20.70. The market cap stands at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Sangamo Therapeutics, Inc. SGMO shares rose 1.9% to $8.80. The market value of their outstanding shares is at $1.0 billion.
  •  

Losers

  • Miragen Therapeutics, Inc. MGEN stock plummeted 16.6% to $0.57 during Thursday's pre-market session. The market cap stands at $20.4 million. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.
  • Diffusion Pharmaceuticals, Inc. DFFN stock declined 11.3% to $0.51. The market value of their outstanding shares is at $3.9 million.
  • Tocagen, Inc. TOCA shares declined 4.4% to $0.69. The market cap stands at $15.0 million.
  • Assembly Biosciences, Inc. ASMB shares fell 3.7% to $17.05. The market cap stands at $427.1 million. The most recent rating by Mizuho, on October 16, is at Buy, with a price target of $20.00.
  • Momenta Pharmaceuticals, Inc. MNTA stock fell 1.7% to $15.44. The market cap stands at $1.6 billion. The most recent rating by SunTrust Robinson Humphrey, on November 12, is at Buy, with a price target of $29.00.
  • Envista Holdings, Inc. NVST shares decreased by 1.0% to $27.89. The market cap seems to be at $4.6 billion.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!